Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $18.6500 (-5.52%) ($18.2500 - $19.9900) on Fri. May. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.88% (three month average) | RSI | 53 | Latest Price | $18.6500(-5.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.3% a day on average for past five trading days. | Weekly Trend | TGTX advances 0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) ARKK(56%) IBB(55%) IWO(55%) | Factors Impacting TGTX price | TGTX will decline at least -4.44% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-17%) DRIV(-3%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.44% (StdDev 8.88%) | Hourly BBV | 0 () | Intraday Trend | -5.9% | | | |
|
Resistance Level | $19.04 | 5 Day Moving Average | $20.23(-7.81%) | 10 Day Moving Average | $20.1(-7.21%) | 20 Day Moving Average | $19.04(-2.05%) | To recent high | -14.6% | To recent low | 161.2% | Market Cap | $2.362b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |